Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Rhodococcus equi (macrolide-susceptible + 48h) |
0.12 |
0.25 |
≤0.06 - 0.5 |
Clarithromycin (Biaxin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
≤0.5 |
≤0.5 |
≤0.5 - >8 |
Rifampicin (Rifampin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
0.5 |
1 |
≤0.25 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
1 |
1 |
0.5 - 1 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
1 |
2 |
≤0.25 - 2 |
Gentamicin (Gentamycin, Garamycin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
2 |
2 |
1 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
2 |
2 |
1 - >4 |
Enrofloxacin |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
2 |
4 |
0.25 - >4 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
2 |
4 |
1 - 4 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
>8 |
>8 |
0.5 - >8 |
Ceftiofur |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
>8 |
>8 |
0.5 - >8 |
Ceftiofur |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
>16 |
>16 |
4 - >16 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
16 |
32 |
8 - 64 |
Chloramphenicol (Chloromycetin) |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
>64 |
>64 |
≤4 - >64 |
Tilmicosin |
1042 |
Rhodococcus equi (macrolide-susceptible + 48h) |
>64 |
>64 |
>64 - ? |
Tulathromycin |
1042 |